Literature DB >> 24866874

The clinical approach to autonomic failure in neurological disorders.

Eduardo E Benarroch1.   

Abstract

Central or peripheral neurological disorders can manifest with autonomic failure or autonomic hyperactivity, which may affect the sympathetic, parasympathetic and/or enteric nervous systems. Disorders causing autonomic failure can be classified according to the presence or absence of associated neurological manifestations, such as peripheral neuropathy or parkinsonism, and their temporal profile (acute or subacute, chronic progressive, static, or episodic). A systematic approach allows focused evaluation to detect treatable, potentially disabling or life-threatening conditions. Subacute isolated autonomic failure affecting sympathetic, parasympathetic and enteric nervous system function, in various combinations, occurs in autoimmune autonomic ganglionopathy, which might be the first manifestation of an underlying neoplasm. Autonomic failure can be an important feature of several types of peripheral neuropathy, including sensorimotor peripheral neuropathies, sensory ganglionopathy, and distal painful peripheral neuropathies. Progressive autonomic failure occurs in neurodegenerative synucleinopathies such as multiple system atrophy and Lewy body disorders. Autonomic failure may also occur in hereditary leukoencephalopathies or prion disorders. This Review outlines the clinical approach to patients with generalized autonomic failure, focusing predominantly on classification and diagnosis, but also touching briefly on treatment and management.

Entities:  

Mesh:

Year:  2014        PMID: 24866874     DOI: 10.1038/nrneurol.2014.88

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN: 1759-4758            Impact factor:   42.937


  157 in total

1.  The clinical use of the Valsalva maneuver.

Authors:  R W BOOTH; J M RYAN
Journal:  Heart Bull       Date:  1961 Nov-Dec

2.  Treatment-induced diabetic neuropathy: a reversible painful autonomic neuropathy.

Authors:  Christopher H Gibbons; Roy Freeman
Journal:  Ann Neurol       Date:  2010-04       Impact factor: 10.422

Review 3.  Bladder dysfunction in Parkinsonism: mechanisms, prevalence, symptoms, and management.

Authors:  Kristian Winge; Clare J Fowler
Journal:  Mov Disord       Date:  2006-06       Impact factor: 10.338

4.  Clinical features and natural history of multiple system atrophy. An analysis of 100 cases.

Authors:  G K Wenning; Y Ben Shlomo; M Magalhães; S E Daniel; N P Quinn
Journal:  Brain       Date:  1994-08       Impact factor: 13.501

5.  Progression of putaminal degeneration in multiple system atrophy: a serial diffusion MR study.

Authors:  Klaus Seppi; Michael F H Schocke; Katherina J Mair; Regina Esterhammer; Christoph Scherfler; Felix Geser; Christian Kremser; Sylvia Boesch; Werner Jaschke; Werner Poewe; Gregor K Wenning
Journal:  Neuroimage       Date:  2006-01-27       Impact factor: 6.556

Review 6.  From genes to pain: Na v 1.7 and human pain disorders.

Authors:  Sulayman D Dib-Hajj; Theodore R Cummins; Joel A Black; Stephen G Waxman
Journal:  Trends Neurosci       Date:  2007-10-22       Impact factor: 13.837

Review 7.  The neural control of micturition.

Authors:  Clare J Fowler; Derek Griffiths; William C de Groat
Journal:  Nat Rev Neurosci       Date:  2008-06       Impact factor: 34.870

8.  Ganglionic acetylcholine receptor autoantibody: oncological, neurological, and serological accompaniments.

Authors:  Andrew McKeon; Vanda A Lennon; Daniel H Lachance; Robert D Fealey; Sean J Pittock
Journal:  Arch Neurol       Date:  2009-06

9.  α-Synuclein in cutaneous autonomic nerves.

Authors:  Ningshan Wang; Christopher H Gibbons; Jacob Lafo; Roy Freeman
Journal:  Neurology       Date:  2013-10-02       Impact factor: 9.910

10.  Genotype, echocardiography, and survival in familial transthyretin amyloidosis.

Authors:  Adelaide M Arruda-Olson; Steven R Zeldenrust; Angela Dispenzieri; Morie A Gertz; Fletcher A Miller; Suzette J Bielinski; Kyle W Klarich; Christopher G Scott; Martha Grogan
Journal:  Amyloid       Date:  2013-10-16       Impact factor: 7.141

View more
  14 in total

Review 1.  Orthostatic hypotension: managing a difficult problem.

Authors:  Pearl K Jones; Brett H Shaw; Satish R Raj
Journal:  Expert Rev Cardiovasc Ther       Date:  2015-10-01

2.  Successful long-term ambulatory norepinephrine infusions in a patient with pure autonomic failure.

Authors:  A Zekeridou; P Michel; F Medlin; D Hayoz; P H Lalive; T Kuntzer
Journal:  Clin Auton Res       Date:  2015-07-03       Impact factor: 4.435

3.  Refined Quantitation of Sweat Gland Innervation.

Authors:  Karla Minota; Ann M Schmeichel; Jade A Gehrking; Jay N Mandrekar; Phillip A Low; Wolfgang Singer
Journal:  J Neuropathol Exp Neurol       Date:  2019-05-01       Impact factor: 3.685

4.  Editorial: Autonomic Neuropathy and Cardiovascular Disease in Aging.

Authors:  A Shams; J E Morley
Journal:  J Nutr Health Aging       Date:  2018       Impact factor: 4.075

Review 5.  Paraneoplastic autoimmune autonomic ganglionopathy as the first symptom of bladder cancer: a case report and review of literature.

Authors:  Carmen de Rojas Leal; José María Lage-Sánchez; Javier Pinel-Ríos; Olmo León Plaza; Omar Hamad-Cueto; Maria Teresa Dawid de Vera; Marc Stefan Dawid-Milner
Journal:  Neurol Sci       Date:  2022-04-28       Impact factor: 3.830

Review 6.  Pathophysiology and Treatment of Orthostatic Hypotension in Parkinsonian Disorders.

Authors:  Dong In Sinn; Christopher H Gibbons
Journal:  Curr Treat Options Neurol       Date:  2016-06       Impact factor: 3.598

7.  Autonomic function testing in spinocerebellar ataxia type 2.

Authors:  Elisabetta Indelicato; Alessandra Fanciulli; Jean Pierre Ndayisaba; Wolfgang Nachbauer; Roberta Granata; Julia Wanschitz; Michaela Wagner; Elke R Gizewski; Werner Poewe; Gregor K Wenning; Sylvia Boesch
Journal:  Clin Auton Res       Date:  2018-02-12       Impact factor: 4.435

Review 8.  Juvenile neuronal ceroid lipofuscinosis (Batten disease): current insights.

Authors:  John R Ostergaard
Journal:  Degener Neurol Neuromuscul Dis       Date:  2016-08-01

9.  Safety and Feasibility of Repeated Intrathecal Allogeneic Bone Marrow-Derived Mesenchymal Stromal Cells in Patients with Neurological Diseases.

Authors:  Kuang Pan; Lingna Deng; Peiying Chen; Qingxia Peng; Jingrui Pan; Yanfeng Wu; Yidong Wang
Journal:  Stem Cells Int       Date:  2019-07-25       Impact factor: 5.443

Review 10.  Potential Interactions between the Autonomic Nervous System and Higher Level Functions in Neurological and Neuropsychiatric Conditions.

Authors:  Andrea Bassi; Marco Bozzali
Journal:  Front Neurol       Date:  2015-09-04       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.